Brief: Moberg Pharma Resolves On Rights Issue Of About SEK 100 Mln

Moberg Pharma AB (publ)

28/06/2023 10:08

June 28 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * MOBERG PHARMA RESOLVES ON A RIGHTS ISSUE OF APPROXIMATELY
SEK
100 MILLION
    * SUBSCRIPTION PRICE, ARE EXPECTED TO BE ANNOUNCED NOT LATER
THAN
ON 4 AUGUST 2023
    * INTENDS TO USE NET PROCEEDS TO FINANCE REGISTRATION
ACTIVITIES
AND CLINICAL WORK FOR MOB-015 AS WELL AS PREPARATIONS FOR LAUNCH

Source text for Eikon:  ID:nWkr37dQwB 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))